Cancer immunotherapeutic potential of NKTT320, a novel human invariant natural killer T-cell activating monoclonal antibody

被引：0
|
作者：
Das, Rupali [1 ]
Scheuplein, Felix [2 ]
Guan, Peng [1 ]
Schaub, Robert [2 ]
Nichols, Kim E. [3 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] NKT Therapeut, Waltham, MD USA
[3] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4294
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Defective Invariant Natural Killer T-Cell Suppression in Patients With Type 1 Diabetes
    Nel, Isabelle
    Lehuen, Agnes
    [J]. DIABETES, 2016, 65 (08) : 2121 - 2123
  • [32] NATURAL-KILLER AND T-CELL POTENTIATION BY MONOCLONAL IGG AGAINST NATURAL-KILLER-CELL FCR(IGG) OR THE T3-COMPLEX
    JONDAL, M
    KULLMAN, C
    ALTER, MB
    LJUNGGREN, K
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1986, 23 (06) : 639 - 645
  • [33] A novel prognostic model for extranodal natural killer/T-cell lymphoma
    Jia-Jia Huang
    Ying-Jie Zhu
    Yi Xia
    Wei Zhao
    Tong-Yu Lin
    Wen-Qi Jiang
    Hui-Qiang Huang
    Zhi-Ming Li
    [J]. Medical Oncology, 2012, 29 : 2183 - 2190
  • [34] Novel target and treatment agents for natural killer/T-cell lymphoma
    Xiao-Peng Tian
    Yi Cao
    Jun Cai
    Yu-Chen Zhang
    Qi-Hua Zou
    Jin-Ni Wang
    Yu Fang
    Jia-Hui Wang
    Song-Bin Guo
    Qing-Qing Cai
    [J]. Journal of Hematology & Oncology, 16
  • [35] Novel target and treatment agents for natural killer/T-cell lymphoma
    Tian, Xiao-Peng
    Cao, Yi
    Cai, Jun
    Zhang, Yu-Chen
    Zou, Qi-Hua
    Wang, Jin-Ni
    Fang, Yu
    Wang, Jia-Hui
    Guo, Song-Bin
    Cai, Qing-Qing
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [36] A novel prognostic model for extranodal natural killer/T-cell lymphoma
    Huang, Jia-Jia
    Zhu, Ying-Jie
    Xia, Yi
    Zhao, Wei
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    Li, Zhi-Ming
    [J]. MEDICAL ONCOLOGY, 2012, 29 (03) : 2183 - 2190
  • [37] Development of Novel Therapeutic Strategy for Heart Failure via Activating Invariant Natural Killer T Cells
    Ishimori, Naoki
    Saito, Akimichi
    Kinugawa, Shintaro
    Mizushima, Wataru
    Shirakawa, Ryousuke
    Tsutsui, Hiroyuki
    [J]. JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S158 - S158
  • [38] STIMULATION AND EXPANSION OF A HUMAN T-CELL SUBPOPULATION BY A MONOCLONAL-ANTIBODY TO T-CELL RECEPTOR MOLECULE
    WANG, CY
    BUSHKIN, Y
    PICA, R
    LANE, C
    MCGRATH, H
    POSNETT, DN
    [J]. HYBRIDOMA, 1986, 5 (03): : 179 - 190
  • [39] Inhibition of antitumor immunity by invariant natural killer T cells in a T-cell lymphoma model in vivo
    Renukaradhya, Gourapura J.
    Sriram, Venkataraman
    Du, Wenjun
    Gervay-Hague, Jacquelyn
    Van Kaer, Luc
    Brutkiewicz, Randy R.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (12) : 3045 - 3053
  • [40] Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients
    Balreira, Andrea
    Macedo, Maria F.
    Girao, Cristina
    Rodrigues, Lorena G.
    Oliveira, Joaa P.
    Miranda, Maria Clara Sa
    Arosa, Fernando A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (04) : 601 - 604
12345